University of Vermont

The University of Vermont Cancer Center

Bio for Christopher Jones, Ph.D.
Christopher Jones, Ph.D.

Christopher Jones, Ph.D.

Assistant Professor
Health Economist
Department of Surgery

Contact Information
Office Location:
CCTS Office, Courtyard at Given Rm 363


M.S., Human Biology, University of Oxford, Oxford, England, 2000
Ph.D., Health Economics, University of Oxford, Oxford, England, 2006
NICE Fellow in Health Economics, Royal Institute of Psychiatry & University College, London, 2003 - 2007

Academic Appointments

Assistant Professor, Department of Surgery; Director, Global Health Economics Unit, Center for Clinical and Translational Science, University of Vermont College of Medicine, Burlington, VT 2011 - present
Faculty Member and Research Associate, Johns Hopkins University, 2006 - 2007

Awards and Honors

CSL-Behring 1-year Certificate of Appreciation, 2011
Overseas Research Award, British Government, 2000 - 2003


Jones CA, Sills ES. Contrasting selected reproductive challenges of today with those of antiquity--the past is prologue. Ulster Med J. 2013 Sep;82(3):150-6.

Jones CA, Petrozzino JJ, Hoesche J, Krol EM, Freeman K. Perceptions about time for normalization of international normalized ratio in patients requiring acute warfarin reversal when using fresh-frozen plasma. Am J Emerg Med. 2013 May;31(5):878-9.

Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA. Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia. Dovepress Journal: ClinicoEconomics and Outcomes Research 5, 2013;119-124.

Sills ES, Collins GS, Salem SA, Jones CA, Peck AC and Salem RD. Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients. Reproductive Biology and Endocrinology. 2012;10:67.

Straughen J, Salihu HM, Keith L, Petrozzino J, Jones C. Obligatory versus elective single embryo transfer: a population-based analysis. J Reprod Med. 2013;58(3-4):95-100.

Haddad E, Berger M, Wang ECY, Jones CA, Baggish J and M Bexon. Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency. J Clin Immunol. 2012 Apr; 32(2):281-9.

Menzin J, Hoesche J, Friedman M, Nichols C, Bergman GE, Crowther M, Garcia D, and Jones C. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost. 2012;10:596-605.

Menzin J, White LA, Friedman M, Nichols C, Menzin J, Hoesche J, Bergman G and Jones C. Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding: an analysis of electronic health records. Thromb Haemost.2012 Apr; 107(4):662-72.

Jones C, Rojavin M and J Baggish. Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety. J Pharm Health Serv Res. 2012;3(1):41-47.

Complete List of Publications